Revvity | Les Charges D'Exploitation



Operating Expenses Changement Date
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Agilent USD 1.37B 63M 2025-04
Align Technology USD 849.42M 1.25M 2025-06
Bio Techne USD 340.82M 63.35M 2025-06
Bio-Rad Laboratories USD 574.5M 12.8M 2025-06
Bruker USD 785.5M 15.9M 2025-06
Celltrion KRW 718.99B 24.68B 2025-06
Charles River Laboratories USD 899.8M 9.7M 2025-06
Cspc Pharmaceutical CNY 5.22B 248.9M 2025-03
Danaher USD 5.18B 718M 2025-06
Dentsply International USD 825M 9M 2025-06
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Divis Laboratories Ltd 17.93B 130M 2025-06
Edwards Lifesciences USD 1.1B 83.4M 2025-06
Exact Sciences USD 813.23M 10.44M 2025-06
Hologic USD 762.9M 249.4M 2025-06
Illumina USD 845M 65M 2025-06
Intuitive Surgical USD 1.69B 17.8M 2025-06
IQVIA Holdings USD 3.46B 124M 2025-06
Kangmei Pharma CNY 1.29B 13.37M 2025-03
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Laboratory Of America USD 3.06B 51.8M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 19.8M 9.46M 2024-12
Mettler Toledo International USD 717.51M 35.71M 2025-06
Myriad Genetics USD 224.9M 24.7M 2025-03
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pharma Mar EUR 32.29M 9.66M 2025-06
Qiagen NV USD 397.57M 39.27M 2025-06
Quest Diagnostics USD 2.32B 17M 2025-06
Quidel USD 615.7M 28.4M 2025-06
Repligen USD 176.41M 13.82M 2025-06
Revvity USD 629.52M 36.99M 2025-06
Sartorius EUR 722.5M 23.1M 2025-06
Sino Biopharmaceutical CNY 11.66B 352.34M 2024-12
Thermo Fisher Scientific USD 8.94B 291M 2025-06
Tilray USD 253.17M 16.55M 2024-11
Waters USD 583.12M 73.16M 2025-06
Zz Pientze Pharmaceu 1.96B 275.44K 2025-03


Revvity Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.